JPMorgan Cuts FS KKR's Credit Line by $648M, KKR Forced to Inject $300M — Private Credit Cracks Widen

Some lenders may have walked away from the syndicate entirely rather than roll over their commitments, per the fund's own filing.

KKR's $300 Million Rescue — The Details

Three days after the bank cuts, KKR announced what it called "Strategic Value Enhancement Actions." The fund is getting a bailout.

KKR is injecting $150 million in preferred equity directly into FSK. It's launching a tender offer to buy $150 million in common shares at $11 apiece from investors who want out. The fund's board separately authorized a $300 million share repurchase program. And KKR agreed to waive half its incentive fees for the next four quarters, according to reporting from CNBC and edgen.tech.

When a fund manager voluntarily gives up fees, they're trying to stop confidence from collapsing.

The Numbers Are Bad

FSK reported $560 million in net losses for Q1 2026 — that's $2 per share on roughly 280 million shares outstanding, according to CNBC. Net asset value dropped approximately 10%.

Nonaccrual loans — the ones that have stopped paying interest — jumped to 8.1% of the portfolio from 5.5% at year-end 2024. That's nearly a 50% increase in problem loans in one quarter.

Two names are now confirmed in nonaccrual status: Medallia, a software company, and Affordable Care, a dental services firm. FSK President Daniel Pietrzak disclosed both on a Monday analyst call, according to CNBC.

The fund's stock has fallen nearly 50% over the past year and trades at a deep discount to net asset value. Moody's downgraded FSK to junk status in March, citing mounting portfolio stress and a 16.4% concentration in software and related services, per edgen.tech.

The Covenant Change

The JPMorgan-led banks didn't just cut the credit line. They also lowered the minimum shareholders' equity floor from $5.05 billion to $3.75 billion.

That's a $1.3 billion reduction in the covenant floor. The banks adjusted the rules so FSK doesn't technically default even as its asset values keep falling.

That signals trouble, not confidence. The banks are protecting themselves from a technical default while reducing their own exposure. They're loosening the seatbelt while stepping out of the car.

Edgen.tech noted that the covenant change "suggests lenders are bracing for further deterioration."

What the Reporting Misses

Most outlets are framing KKR's $300 million injection as a "show of confidence" in the fund. That's the KKR press release.

Look at the sequence. Banks cut the line on May 8. KKR announced support days later. That is a reactive rescue, not a proactive vote of confidence. KKR didn't wake up bullish — they responded to lenders reducing exposure.

Pietrzak told analysts on Monday, per CNBC: "We are disappointed by our recent performance." But the same call included the claim that KKR's actions "support our view of a disconnect in the trading price of FSK versus its intrinsic value." They're blaming the market for not appreciating the fund's true worth.

The stock is down 50% in a year. Nonaccruals nearly doubled in one quarter. Moody's called it junk. The market is reading the portfolio correctly.

What FSK Said It Will Do Next

Executives said FSK will sharply curtail new investments to focus on stabilizing the existing portfolio, according to edgen.tech. The stated goal is moving toward a smaller, less leveraged balance sheet.

The growth phase is over. FSK is in triage mode.

Why This Matters Beyond One Fund

FSK is a business development company — it lends to mid-market businesses that traditional banks won't touch. When BDCs start posting 8% nonaccrual rates and junk credit ratings, that pain flows directly to the companies that borrowed from them. Refinancing gets harder. Covenants tighten. Businesses that were already stretched start failing.

Private credit was sold to institutional investors — pension funds, endowments, insurance companies — as a stable, high-yield alternative to public markets. The pitch was that illiquidity was a feature, not a bug. You couldn't panic-sell, so you wouldn't.

What nobody tested was: what happens when the underlying loans stop performing at scale, AND the banks funding the fund's own leverage start pulling back, ALL at the same time?

That's the scenario playing out right now — at FSK, and likely at other funds that haven't had to disclose it yet.

The Blackstone story was about investors trying to get out. The FSK story is about lenders trying to get out. Those are two different alarm bells — and they're ringing simultaneously.